Global Bio-pharma Market Research Report 2018

payment-methods.png
Secure Payment Methods

Global Bio-pharma market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by ResearchVector Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Bio-pharma to 2023 offers detailed coverage of guanidine Bio-pharma industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading Bio-pharma producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes following contents:

  • Bio-pharma Product details, including pictures and technical specifications
  • Bio-pharma manufacturers, distributors and channels
  • Major players present in the Bio-pharma
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Pfizer
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson Services
  • Sanofi, Amgen
  • AbbVie
  • Merck & Co., Inc
  • Biogen Idec
  • Bayer AG
  • Eli Lilly and Company
  • Novartis AG GlaxoSmithKline Plc
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC
  • Abbott Laboratories
  • On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Granulocyte-Colony Stimulating Factor (G-CSF)
  • Interferons
  • Recombinant Human Insulin
  • Erythropoietin
  • Vaccines
  • Growth Hormones
  • Purified Proteins
  • Others
  • On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
  • Metabolic Disorders
  • Oncology
  • Neurological Disorders
  • Cardiovascular Diseases
  • Inflammatory and Infectious Diseases
  • Others

Key regions:

North America, Europe, China, Japan, Southeast Asia, India, Pfizer, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Sanofi, Amgen, AbbVie, Merck & Co., Inc, Biogen Idec, Bayer AG, Eli Lilly and Company, Novartis AG GlaxoSmithKline Plc, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Monoclonal Antibodies, Recombinant Proteins, Granulocyte-Colony Stimulating Factor (G-CSF), Interferons, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins, Others, Metabolic Disorders, Oncology, Neurological Disorders, Cardiovascular Diseases, Inflammatory and Infectious Diseases, Others

Additionally, the market is segmented by the following sectors

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Granulocyte-Colony Stimulating Factor (G-CSF)
  • Interferons
  • Recombinant Human Insulin
  • Erythropoietin
  • Vaccines
  • Growth Hormones
  • Purified Proteins
  • Others
  • On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
  • Metabolic Disorders
  • Oncology
  • Neurological Disorders
  • Cardiovascular Diseases
  • Inflammatory and Infectious Diseases
  • Others
  • If you have any special requirements, please let us know and we will offer you the report as you want.

Not only this, figures covering the end user applications are also provided according to the following classification

  • Metabolic Disorders
  • Oncology
  • Neurological Disorders
  • Cardiovascular Diseases
  • Inflammatory and Infectious Diseases
  • Others

In summary, the report serves to study and analyse the Bio-pharma size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bio-pharma, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • Global Bio-pharma Market Research Report 2018
  • 1 Bio-pharma Market Overview
    • 1.1 Product Overview and Scope of Bio-pharma
    • 1.2 Bio-pharma Segment by Type (Product Category)
      • 1.2.1 Global Bio-pharma Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
      • 1.2.2 Global Bio-pharma Production Market Share by Type (Product Category) in 2017
      • 1.2.3 Monoclonal Antibodies
      • 1.2.4 Recombinant Proteins
      • 1.2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
      • 1.2.6 Interferons
      • 1.2.7 Recombinant Human Insulin
      • 1.2.8 Erythropoietin
      • 1.2.9 Vaccines
      • 1.2.10 Growth Hormones
      • 1.2.11 Purified Proteins
      • 1.2.12 Others
    • 1.3 Global Bio-pharma Segment by Application
      • 1.3.1 Bio-pharma Consumption (Sales) Comparison by Application (2013-2025)
      • 1.3.2 Metabolic Disorders
      • 1.3.3 Oncology
      • 1.3.4 Neurological Disorders
      • 1.3.5 Cardiovascular Diseases
      • 1.3.6 Inflammatory and Infectious Diseases
      • 1.3.7 Others
    • 1.4 Global Bio-pharma Market by Region (2013-2025)
      • 1.4.1 Global Bio-pharma Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
      • 1.4.2 North America Status and Prospect (2013-2025)
      • 1.4.3 Europe Status and Prospect (2013-2025)
      • 1.4.4 China Status and Prospect (2013-2025)
      • 1.4.5 Japan Status and Prospect (2013-2025)
      • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
      • 1.4.7 India Status and Prospect (2013-2025)
    • 1.5 Global Market Size (Value) of Bio-pharma (2013-2025)
      • 1.5.1 Global Bio-pharma Revenue Status and Outlook (2013-2025)
      • 1.5.2 Global Bio-pharma Capacity, Production Status and Outlook (2013-2025)
  • 2 Global Bio-pharma Market Competition by Manufacturers
    • 2.1 Global Bio-pharma Capacity, Production and Share by Manufacturers (2013-2018)
      • 2.1.1 Global Bio-pharma Capacity and Share by Manufacturers (2013-2018)
      • 2.1.2 Global Bio-pharma Production and Share by Manufacturers (2013-2018)
    • 2.2 Global Bio-pharma Revenue and Share by Manufacturers (2013-2018)
    • 2.3 Global Bio-pharma Average Price by Manufacturers (2013-2018)
    • 2.4 Manufacturers Bio-pharma Manufacturing Base Distribution, Sales Area and Product Type
    • 2.5 Bio-pharma Market Competitive Situation and Trends
      • 2.5.1 Bio-pharma Market Concentration Rate
      • 2.5.2 Bio-pharma Market Share of Top 3 and Top 5 Manufacturers
      • 2.5.3 Mergers & Acquisitions, Expansion
  • 3 Global Bio-pharma Capacity, Production, Revenue (Value) by Region (2013-2018)
    • 3.1 Global Bio-pharma Capacity and Market Share by Region (2013-2018)
    • 3.2 Global Bio-pharma Production and Market Share by Region (2013-2018)
    • 3.3 Global Bio-pharma Revenue (Value) and Market Share by Region (2013-2018)
    • 3.4 Global Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.5 North America Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.6 Europe Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.7 China Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.8 Japan Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.9 Southeast Asia Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.10 India Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 4 Global Bio-pharma Supply (Production), Consumption, Export, Import by Region (2013-2018)
    • 4.1 Global Bio-pharma Consumption by Region (2013-2018)
    • 4.2 North America Bio-pharma Production, Consumption, Export, Import (2013-2018)
    • 4.3 Europe Bio-pharma Production, Consumption, Export, Import (2013-2018)
    • 4.4 China Bio-pharma Production, Consumption, Export, Import (2013-2018)
    • 4.5 Japan Bio-pharma Production, Consumption, Export, Import (2013-2018)
    • 4.6 Southeast Asia Bio-pharma Production, Consumption, Export, Import (2013-2018)
    • 4.7 India Bio-pharma Production, Consumption, Export, Import (2013-2018)
  • 5 Global Bio-pharma Production, Revenue (Value), Price Trend by Type
    • 5.1 Global Bio-pharma Production and Market Share by Type (2013-2018)
    • 5.2 Global Bio-pharma Revenue and Market Share by Type (2013-2018)
    • 5.3 Global Bio-pharma Price by Type (2013-2018)
    • 5.4 Global Bio-pharma Production Growth by Type (2013-2018)
  • 6 Global Bio-pharma Market Analysis by Application
    • 6.1 Global Bio-pharma Consumption and Market Share by Application (2013-2018)
    • 6.2 Global Bio-pharma Consumption Growth Rate by Application (2013-2018)
    • 6.3 Market Drivers and Opportunities
      • 6.3.1 Potential Applications
      • 6.3.2 Emerging Markets/Countries
  • 7 Global Bio-pharma Manufacturers Profiles/Analysis
    • 7.1 Pfizer
      • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.1.2 Bio-pharma Product Category, Application and Specification
        • 7.1.2.1 Product A
        • 7.1.2.2 Product B
      • 7.1.3 Pfizer Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.1.4 Main Business/Business Overview
    • 7.2 F. Hoffmann-La Roche AG
      • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.2.2 Bio-pharma Product Category, Application and Specification
        • 7.2.2.1 Product A
        • 7.2.2.2 Product B
      • 7.2.3 F. Hoffmann-La Roche AG Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.2.4 Main Business/Business Overview
    • 7.3 Johnson & Johnson Services
      • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.3.2 Bio-pharma Product Category, Application and Specification
        • 7.3.2.1 Product A
        • 7.3.2.2 Product B
      • 7.3.3 Johnson & Johnson Services Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.3.4 Main Business/Business Overview
    • 7.4 Sanofi, Amgen
      • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.4.2 Bio-pharma Product Category, Application and Specification
        • 7.4.2.1 Product A
        • 7.4.2.2 Product B
      • 7.4.3 Sanofi, Amgen Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.4.4 Main Business/Business Overview
    • 7.5 AbbVie
      • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.5.2 Bio-pharma Product Category, Application and Specification
        • 7.5.2.1 Product A
        • 7.5.2.2 Product B
      • 7.5.3 AbbVie Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.5.4 Main Business/Business Overview
    • 7.6 Merck & Co., Inc
      • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.6.2 Bio-pharma Product Category, Application and Specification
        • 7.6.2.1 Product A
        • 7.6.2.2 Product B
      • 7.6.3 Merck & Co., Inc Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.6.4 Main Business/Business Overview
    • 7.7 Biogen Idec
      • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.7.2 Bio-pharma Product Category, Application and Specification
        • 7.7.2.1 Product A
        • 7.7.2.2 Product B
      • 7.7.3 Biogen Idec Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.7.4 Main Business/Business Overview
    • 7.8 Bayer AG
      • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.8.2 Bio-pharma Product Category, Application and Specification
        • 7.8.2.1 Product A
        • 7.8.2.2 Product B
      • 7.8.3 Bayer AG Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.8.4 Main Business/Business Overview
    • 7.9 Eli Lilly and Company
      • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.9.2 Bio-pharma Product Category, Application and Specification
        • 7.9.2.1 Product A
        • 7.9.2.2 Product B
      • 7.9.3 Eli Lilly and Company Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.9.4 Main Business/Business Overview
    • 7.10 Novartis AG GlaxoSmithKline Plc
      • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.10.2 Bio-pharma Product Category, Application and Specification
        • 7.10.2.1 Product A
        • 7.10.2.2 Product B
      • 7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.10.4 Main Business/Business Overview
    • 7.11 Bristol-Myers Squibb Company
    • 7.12 AstraZeneca PLC
    • 7.13 Abbott Laboratories
  • 8 Bio-pharma Manufacturing Cost Analysis
    • 8.1 Bio-pharma Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Price Trend of Key Raw Materials
    • 8.1.3 Key Suppliers of Raw Materials
    • 8.1.4 Market Concentration Rate of Raw Materials
    • 8.2 Proportion of Manufacturing Cost Structure
    • 8.2.1 Raw Materials
    • 8.2.2 Labor Cost
    • 8.2.3 Manufacturing Expenses
    • 8.3 Manufacturing Process Analysis of Bio-pharma
  • 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    • 9.1 Bio-pharma Industrial Chain Analysis
    • 9.2 Upstream Raw Materials Sourcing
    • 9.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2017
    • 9.4 Downstream Buyers
  • 10 Marketing Strategy Analysis, Distributors/Traders
    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List
  • 11 Market Effect Factors Analysis
    • 11.1 Technology Progress/Risk
      • 11.1.1 Substitutes Threat
      • 11.1.2 Technology Progress in Related Industry
    • 11.2 Consumer Needs/Customer Preference Change
    • 11.3 Economic/Political Environmental Change
  • 12 Global Bio-pharma Market Forecast (2018-2025)
    • 12.1 Global Bio-pharma Capacity, Production, Revenue Forecast (2018-2025)
      • 12.1.1 Global Bio-pharma Capacity, Production and Growth Rate Forecast (2018-2025)
      • 12.1.2 Global Bio-pharma Revenue and Growth Rate Forecast (2018-2025)
      • 12.1.3 Global Bio-pharma Price and Trend Forecast (2018-2025)
    • 12.2 Global Bio-pharma Production, Consumption , Import and Export Forecast by Region (2018-2025)
      • 12.2.1 North America Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.2 Europe Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.3 China Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.4 Japan Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.5 Southeast Asia Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.6 India Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.3 Global Bio-pharma Production, Revenue and Price Forecast by Type (2018-2025)
    • 12.4 Global Bio-pharma Consumption Forecast by Application (2018-2025)
  • 13 Research Findings and Conclusion
  • 14 Appendix
    • 14.1 Methodology/Research Approach
      • 14.1.1 Research Programs/Design
      • 14.1.2 Market Size Estimation
      • 14.1.3 Market Breakdown and Data Triangulation
    • 14.2 Data Source
      • 14.2.1 Secondary Sources
      • 14.2.2 Primary Sources
    • 14.3 Disclaimer

Request a FREE Sample


Our Happy Customers

Request a FREE Sample